Abstract:Osteoporosis is a disease that causes low bone mass and deterioration of bone microarchitecture. Puerarin is a natural isoflavone compound that has been shown to possess anti-inflammatory, antioxidant and ameliorative effects on osteoporosis with less adverse reactions. However, its fast metabolism and low oral bioavailability limit its application. This study aimed to prepare D-α-tocopherol polyethylene glycol 1000 succinate (TPGS)- modified Puerarin Long Circulating Liposomes (TPGS-Puerarin-liposomes), in order to improve the oral bioavailability of puerarin, before evaluation of its pharmacological activity in vitro and in vivo. We employed film dispersion method to develop TPGS-Puerarin-liposomes before appropriate characterizations. Afterwards, we utilized in vivo imaging, pharmacokinetic analysis and in vitro drug release testing to further evaluate the in vivo and in vitro delivery efficiency. In addition, we established a castrated osteoporosis rat model to observe the changes in femur tissue structure and bone micromorphology via hematoxylin-eosin (HE) staining and Micro Computed Tomography (Micro CT). Besides, levels of oxidative stress and inflammatory indicators, as well as expression of wnt/β-catenin pathway-related proteins were detected. In terms of physiochemical properties, the respective mean particle size (PS) and zeta potential (ZP) of TPGS-Puerarin-liposomes were 76.63±0.59 nm and -25.54±0.11 mV. The liposomal formulation exhibited encapsulation efficiency (EE) of 95.08±0.25% and drug loading (DL) of 7.84±0.07%, along with excellent storage stability. Compared with free drugs, the TPGS-Puerarin-liposomes demonstrated a sustained release effect and could increase blood concentration of puerarin in rats, thereby significantly improving its bioavailability. Also, in vivo studies have confirmed potential of the liposomes to promote bone tissue targeting and accumulation of puerarin, coupled with significant improvement of the osteoporotic status. Besides, the liposomes could also reduce levels of oxidative stress and inflammatory factors in serum and bone tissue. Additionally, we discovered that TPGS-Puerarin-liposomes increased Wnt, β-catenin and T-cell factor (TCF) expressions at protein level in the wnt/β-catenin signaling pathway. This study has demonstrated the potential of TPGS-Puerarin-liposomes for treatment of osteoporosis.

Quality Evaluation of Puerarin Proliposomes

Improvement in Solubility and Bioavailability of Puerarin by Mechanochemical Preparation

Preparation and Preliminary Safety Evaluation of Carboplatin Proliposomes

Preparation and in Vitro Characterization of Propylgallate Liposomes

The Study to Reduce the Hemolysis Side Effect of Puerarin by a Submicron Emulsion Delivery System

Quality Evaluation of Drug-Loaded Liposomes

Preparation and Quality Evaluation of Irinotecan Hydrochloride Lyophilized Liposomes

Preparation of Puerarin Long Circulating Liposomes and Its Effect on Osteoporosis in Castrated Rats

Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides

Preparation and molecular interaction of organic solvent-free piperine pro-liposome from soy lecithin

Enhancing the bioaccessibility of puerarin through the collaboration of high internal phase Pickering emulsions with β-carotene

Optimized preparation of vinpocetine proliposomes by a novel method and in vivo evaluation of its pharmacokinetics in New Zealand rabbits

Study on Encapsulation Efficiency and in Vitro Release of Baicalin Liposomes

Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery.

Determination of the Entrapment Efficiency of Oral Progesterone Proliposome Preparation

Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: Formulation optimization, characterization, oral bioavailability and tissue distribution in rats

FORMULATION AND EVALUATION OF CURCUMIN LOADED LIPOSOME AND ITS BIO-ENHANCEMENT

Determination of Contents of Functional Epirubicin Liposomes and Invitro Release Rate

Preparation and Characterization of Universal Liquid Proliposomes Encapsulating Water-soluble Efficacious Substances

Production Process of Pueraria Flavonoids Particle and Its Properties

Curcumin liposomes prepared with milk fat globule membrane phospholipids and soybean lecithin.